• Info
  • Insider Ownership

Insider Trading & Ownership of Thomas Garner

Location
San Diego, CA
Summary
The estimated net worth of Thomas Garner is at least $1,001,939 dollars as of 10 Mar 2026. Thomas Garner is the EVP, Chief Commercial Officer of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $762.7K. Thomas Garner is the SVP, Chief Commercial Officer of LEXICON PHARMACEUTICALS, INC. and owns shares of LEXICON PHARMACEUTICALS, INC. (LXRX) stock worth about $239.2K.
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Thomas Garner and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Thomas Garner has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,001,939.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ACADIA PHARMACEUTICALS INC ($762,703).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Thomas Garner

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACAD ACADIA PHARMACEUTICALS INC EVP, Chief Commercial Officer $762,703 06 Mar 2026
LXRX LEXICON PHARMACEUTICALS, INC. SVP, Chief Commercial Officer $239,236 08 Feb 2024

Insider Transactions Reported by Thomas Garner:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored